Franklin Genomic Advancements ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.50
資產淨值: 33.36
成立日期: 25/02/2020
 
分析
市值分佈:
68.74%
大市值
13.54%
中市值
0.89%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/03/2026 05:56) 總持有投資項目: 52  
0%
 
100%
     10大 (41.46%)
代號 名稱 佔比% 持有日期
TWSTTwist Bioscience Corp1.3628/02/2026
TVTXTravere Therapeutics1.3428/02/2026
VCYTVeracyte1.1128/02/2026
RGENRepligen Corp1.0728/02/2026
SUVPFSartorius AG1.0628/02/2026
STOKStoke Therapeutics1.0028/02/2026
DHRDanaher Corp0.9828/02/2026
GRALGRAIL Inc.0.9828/02/2026
TMOThermo Fisher Scientific0.9128/02/2026
BEAMBeam Therapeutics0.8928/02/2026
CRSPCRISPR Therapeutics AG0.8528/02/2026
IQVIQVIA Holdings0.8028/02/2026
CDNSCadence Design Systems0.7328/02/2026
QGENQiagen NV0.7028/02/2026
CDNACareDx0.6228/02/2026
AAgilent Technologies0.6128/02/2026
RAREUltragenyx Pharmaceutical0.6128/02/2026
CPRXCatalyst Pharmaceuticals0.5728/02/2026
ARQTArcutis Biotherapeutics0.4928/02/2026
PRAXPraxis Precision Medicines0.4728/02/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.